21, 2004, GSK: Knowingly promoted the sale and use of Zofran for a variety of conditions other than those for which its use was approved as safe and effective by the FDA (including hyperemesis and pregnancy-related nausea) Made and/or disseminated unsubstantiated and/or false representations or statements about the safety and efficacy of Zofran concerning its use for conditions, including hyperemesis and pregnancy-related nausea Offered and paid illegal kickbacks to health care professionals to encourage them to promote and prescribe Zofran, in violation of federal anti-kickback laws The DOJ described the settlement as the largest health care fraud settlement in U.S
The clinical signal is now catching up to what the rodent data has been saying for a decade
**Enhances thermogenesis** -- you produce more body heat, which requires caloric energy Published data from the Phase 2 trial showed measurable increases in metabolic rate among retatrutide participants that were not observed in the placebo group or in comparable semaglutide/tirzepatide trials
High-Dose Semaglutide (Up to 16 mg) in People With Type 2 Diabetes and Overweight or Obesity: A Randomized, Placebo-Controlled, Phase 2 Trial
What athletes need to know about collagen
Your pharmacist will advise based on your individual needs